• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双环肽抑制剂与蛋白酶靶标呈现出较大的接触界面。

Bicyclic peptide inhibitor reveals large contact interface with a protease target.

机构信息

Institute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland.

出版信息

ACS Chem Biol. 2012 May 18;7(5):817-21. doi: 10.1021/cb200478t. Epub 2012 Feb 15.

DOI:10.1021/cb200478t
PMID:22304751
Abstract

From a large combinatorial library of chemically constrained bicyclic peptides we isolated a selective and potent (K(i) = 53 nM) inhibitor of human urokinase-type plasminogen activator (uPA) and crystallized the complex. This revealed an extended structure of the peptide with both peptide loops engaging the target to form a large interaction surface of 701 Å(2) with multiple hydrogen bonds and complementary charge interactions, explaining the high affinity and specificity of the inhibitor. The interface resembles that between two proteins and suggests that these constrained peptides have the potential to act as small protein mimics.

摘要

我们从一个大型的化学约束双环肽组合文库中分离出一种对人尿激酶型纤溶酶原激活物(uPA)具有选择性和高效抑制活性的抑制剂(Ki = 53 nM),并对其复合物进行了结晶。该复合物揭示了肽的扩展结构,两个肽环与靶标结合,形成一个具有 701 Å2 的大相互作用表面,其中有多个氢键和互补的电荷相互作用,解释了抑制剂的高亲和力和特异性。该界面类似于两个蛋白质之间的界面,表明这些约束肽具有作为小蛋白模拟物的潜力。

相似文献

1
Bicyclic peptide inhibitor reveals large contact interface with a protease target.双环肽抑制剂与蛋白酶靶标呈现出较大的接触界面。
ACS Chem Biol. 2012 May 18;7(5):817-21. doi: 10.1021/cb200478t. Epub 2012 Feb 15.
2
A urokinase-type plasminogen activator-inhibiting cyclic peptide with an unusual P2 residue and an extended protease binding surface demonstrates new modalities for enzyme inhibition.一种具有不寻常P2残基和扩展蛋白酶结合表面的尿激酶型纤溶酶原激活物抑制环肽展示了酶抑制的新方式。
J Biol Chem. 2005 Nov 18;280(46):38424-37. doi: 10.1074/jbc.M505933200. Epub 2005 Sep 1.
3
Characterising the Subsite Specificity of Urokinase-Type Plasminogen Activator and Tissue-Type Plasminogen Activator using a Sequence-Defined Peptide Aldehyde Library.利用序列定义的肽醛文库对尿激酶型纤溶酶原激活物和组织型纤溶酶原激活物进行亚基特异性分析。
Chembiochem. 2019 Jan 2;20(1):46-50. doi: 10.1002/cbic.201800395. Epub 2018 Oct 24.
4
Bicyclic peptide inhibitor of urokinase-type plasminogen activator: mode of action.尿激酶型纤溶酶原激活剂的双环肽抑制剂:作用模式
Chembiochem. 2013 Nov 4;14(16):2179-88. doi: 10.1002/cbic.201300335. Epub 2013 Oct 2.
5
A cyclic peptidylic inhibitor of murine urokinase-type plasminogen activator: changing species specificity by substitution of a single residue.一种小鼠尿激酶型纤溶酶原激活剂的环状肽抑制剂:通过单个残基取代改变物种特异性。
Biochem J. 2008 Jun 15;412(3):447-57. doi: 10.1042/BJ20071646.
6
Structural basis for selectivity of a small molecule, S1-binding, submicromolar inhibitor of urokinase-type plasminogen activator.小分子尿激酶型纤溶酶原激活剂的S1结合亚微摩尔抑制剂选择性的结构基础
Chem Biol. 2000 Apr;7(4):299-312. doi: 10.1016/s1074-5521(00)00104-6.
7
Improving binding affinity and stability of peptide ligands by substituting glycines with D-amino acids.通过用 D-氨基酸替代甘氨酸来提高肽配体的结合亲和力和稳定性。
Chembiochem. 2013 Jul 22;14(11):1316-22. doi: 10.1002/cbic.201300228. Epub 2013 Jul 4.
8
Bicyclic peptide antagonists derived from genetically encoded combinatorial libraries.源自基因编码组合文库的双环肽拮抗剂。
Chimia (Aarau). 2011;65(9):677-9. doi: 10.2533/chimia.2011.677.
9
Inhibition of the interaction of urokinase-type plasminogen activator (uPA) with its receptor (uPAR) by synthetic peptides.合成肽对尿激酶型纤溶酶原激活剂(uPA)与其受体(uPAR)相互作用的抑制作用。
Biol Chem. 1997 Mar-Apr;378(3-4):231-7. doi: 10.1515/bchm.1997.378.3-4.231.
10
Structure-directed discovery of potent non-peptidic inhibitors of human urokinase that access a novel binding subsite.通过结构导向发现可作用于新型结合亚位点的人尿激酶强效非肽类抑制剂。
Structure. 2000 May 15;8(5):553-63. doi: 10.1016/s0969-2126(00)00136-2.

引用本文的文献

1
A Beautiful Bind: Phage Display and the Search for Cell-Selective Peptides.一个美妙的困境:噬菌体展示与细胞选择性肽的探索
Viruses. 2025 Jul 12;17(7):975. doi: 10.3390/v17070975.
2
Peptides That Induce the Liquid-Liquid Phase Separation of α-Synuclein.诱导α-突触核蛋白液-液相分离的肽。
J Am Chem Soc. 2025 Jul 9;147(27):24113-24126. doi: 10.1021/jacs.5c08019. Epub 2025 Jun 25.
3
Design, Synthesis, and Antitumor Biological Evaluation of Galaxamide and Its Analogs.海石酰胺及其类似物的设计、合成与抗肿瘤生物学评价
Molecules. 2025 May 29;30(11):2362. doi: 10.3390/molecules30112362.
4
Combination of Coevolutionary Information and Supervised Learning Enables Generation of Cyclic Peptide Inhibitors with Enhanced Potency from a Small Data Set.共进化信息与监督学习相结合可从小数据集生成具有更高效力的环肽抑制剂。
ACS Cent Sci. 2024 Nov 20;10(12):2242-2252. doi: 10.1021/acscentsci.4c01428. eCollection 2024 Dec 25.
5
Protocol for Designing Noncanonical Peptide Binders in OSPREY.OSPREY 中非经典肽配体设计方案
J Comput Biol. 2024 Oct;31(10):965-974. doi: 10.1089/cmb.2024.0669. Epub 2024 Oct 4.
6
DNA encoded peptide library for SARS-CoV-2 3CL protease covalent inhibitor discovery and profiling.用于发现和分析严重急性呼吸综合征冠状病毒2 3CL蛋白酶共价抑制剂的DNA编码肽库
RSC Chem Biol. 2024 Jun 11;5(7):691-702. doi: 10.1039/d4cb00097h. eCollection 2024 Jul 3.
7
DexDesign: an OSPREY-based algorithm for designing de novo D-peptide inhibitors.DexDesign:一种基于 OSPREY 的从头设计 D-肽抑制剂的算法。
Protein Eng Des Sel. 2024 Jan 29;37. doi: 10.1093/protein/gzae007.
8
Strategies for the Construction of Multicyclic Phage Display Libraries.构建多环噬菌体展示文库的策略。
Chembiochem. 2024 May 2;25(9):e202400072. doi: 10.1002/cbic.202400072. Epub 2024 Apr 3.
9
MYC-Targeting Inhibitors Generated from a Stereodiversified Bicyclic Peptide Library.从立体多样化双环肽文库中生成的 MYC 靶向抑制剂。
J Am Chem Soc. 2024 Jan 17;146(2):1356-1363. doi: 10.1021/jacs.3c09615. Epub 2024 Jan 3.
10
Intramolecular Hydrogen Bonding Enables a Zwitterionic Mechanism for Macrocyclic Peptide Formation: Computational Mechanistic Studies of CyClick Chemistry.分子内氢键使两性离子机制能够用于大环肽的形成:CyClick 化学的计算机理研究。
Angew Chem Int Ed Engl. 2023 Oct 9;62(41):e202307210. doi: 10.1002/anie.202307210. Epub 2023 Aug 17.